EUVIMEDEUVIMED entdecken
Fallbericht

Flucloxacillin instantly decreases serum levels of valproic acid: A case report

Douwe H van der Meer iD, Lisa J Elting, Pleun S van Egmond

British Journal of Clinical Pharmacology · 2024

DOI: 10.1111/bcp.16244 ↗

Kurz gefasst

Fallbericht in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Douwe H van der Meer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Isala, Zwolle, The Netherlands. Hauptthemen laut MEDLINE: Valproic Acid, Floxacillin, Drug Interactions, Bipolar Disorder. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Valproic acid (VPA) is used for epilepsy and bipolar disorder. It has near‐complete bioavailability and is primarily metabolized by glucuronosyltransferases and mitochondrial oxidation. This case highlights a 79‐year‐old male with bipolar disorder on VPA therapy that started with flucloxacillin for Staphylococcus aureus bacteraemia and exhibited significantly reduced VPA serum levels. During hospitalization, flucloxacillin treatment correlated with a sharp decline of 75% in VPA total serum levels, a novel drug–drug interaction not previously reported. Nonadherence and absorption issues of VPA were ruled out, confirming flucloxacillin's role in reducing VPA levels. Because free‐fraction serum levels of VPA remained within therapeutic range (5–25 mg/L) and our patient's bipolar disorder remained stable at 1000 mg twice daily, a dose increase was not necessary. Previous reports described cytochrome P450 enzyme induction as the mechanism of flucloxacillin lowering serum levels of immunosuppressants and antimycotics. Because only 10% of VPA is metabolized by cytochrome P450 enzymes, this is not plausible for this case. The proposed mechanism for the VPA–flucloxacillin drug–drug interaction is flucloxacillin as inducer of glucuronosyltransferase enzymes via the pregnane X receptor pathway, accelerating VPA metabolism. Because this case showed that free‐fraction serum levels remained within therapeutic range, it underscores the need for free‐fraction VPA monitoring in bipolar disorder and flucloxacillin therapy. When VPA is used for epilepsy, it is advised to consider alternative antibiotics to avoid this interaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Valproic AcidFloxacillinDrug InteractionsBipolar DisorderAnti-Bacterial AgentsHumansMaleAgedStaphylococcal InfectionsBacteremiaAnticonvulsants

Stichwörter der Autor:innen

druginteractionsflucloxacillinpharmacokineticsprescribingtherapeuticdrug monitoringvalproicacid

Substanzen

Valproic AcidFloxacillinAnti-Bacterial AgentsAnticonvulsants

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Isala, Zwolle, The Netherlands.
  • Department of Neurology, Isala, Zwolle, The Netherlands.

ORCID-Profile: Douwe H van der Meer

Zitieren

APA

van der Meer, D. H., Elting, L. J., & van Egmond, P. S. (2024). Flucloxacillin instantly decreases serum levels of valproic acid: A case report. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16244

Vancouver

van der Meer DH, Elting LJ, van Egmond PS. Flucloxacillin instantly decreases serum levels of valproic acid: A case report. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16244

BibTeX
@article{vanderMeer2024,
  author = {van der Meer, Douwe H and Elting, Lisa J and van Egmond, Pleun S},
  title = {Flucloxacillin instantly decreases serum levels of valproic acid: A case report},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/bcp.16244}
}
Kostenlos starten →